These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10404756)

  • 1. Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome.
    Holm J; Hillarp A; Zöller B; Erhardt L; Berntorp E; Dahlbäck B
    Thromb Haemost; 1999 Jun; 81(6):857-60. PubMed ID: 10404756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance (FV:Q506) and pregnancy.
    Lindqvist PG; Svensson PJ; Marsaál K; Grennert L; Luterkort M; Dahlbäck B
    Thromb Haemost; 1999 Apr; 81(4):532-7. PubMed ID: 10235434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the FV:Q506 mutation in unselected oncology patients.
    Otterson GA; Monahan BP; Harold N; Steinberg SM; Frame JN; Kaye FJ
    Am J Med; 1996 Oct; 101(4):406-12. PubMed ID: 8873512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.
    Middeldorp S; van der Meer J
    Semin Thromb Hemost; 1998; 24(4):363-6. PubMed ID: 9763353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
    Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
    Martinelli I; Cattaneo M; Panzeri D; Mannucci PM
    Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.
    Tosetto A; Castaman G; Cappellari A; Rodeghiero F
    Thromb Haemost; 2000 Nov; 84(5):811-4. PubMed ID: 11127861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.
    Lowe GD; Rumley A; Woodward M; Reid E; Rumley J
    Thromb Haemost; 1999 Jun; 81(6):918-24. PubMed ID: 10404768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension.
    Makris TK; Krespi PG; Hatzizacharias AN; Gialeraki AE; Anastasiadis G; Triposkiadis FK; Mandalaki T; Kyriakidis MK
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):61-5. PubMed ID: 10678272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
    Bossone A; Cappucci F; D'Andrea G; Brancaccio V; Cibelli G; Iannaccone L; Grandone E; Margaglione M
    Haematologica; 2003 Mar; 88(3):286-9. PubMed ID: 12651267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C resistance in anterior ischaemic optic neuropathy.
    Nagy V; Facsko A; Takacs L; Balazs E; Berta A; Balogh I; Edes I; Czuriga I; Pfliegler G
    Acta Ophthalmol Scand; 2004 Apr; 82(2):140-3. PubMed ID: 15043529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
    Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T
    Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden in patients with acute coronary syndromes.
    Durante Mangoni E; Davies GJ; Tuddenham EG; Ruggiero G
    Ann Ital Med Int; 1999; 14(1):15-9. PubMed ID: 10528420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
    Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
    Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.